3-(1,2,3,5,8,8a-Hexahydro-7-indolizinyl)-1H-6-azaindole → 3-(1-Methyl-4-piperidinyl)-5-azaindole
반응식
C1[CH:9]2[N:4]([CH2:5][CH2:6][CH:7]([C:10]3[C:18]4[C:13](=[N:14][CH:15]=[CH:16][CH:17]=4)[NH:12][CH:11]=3)[CH2:8]2)[CH2:3]C1.C1C2N(CC=C(C3C4C(=CN=CC=4)NC=3)C2)CC1>C(O)C.[Pd]>[CH3:3][N:4]1[CH2:9][CH2:8][CH:7]([C:10]2[C:18]3[C:17](=[CH:16][CH:15]=[N:14][CH:13]=3)[NH:12][CH:11]=2)[CH2:6][CH2:5]1참가 물질
5
실험 절차
3-(Octahydro-7-indolizinyl)-1H-7-azaindole (less polar isomer 134.2 mg, 49.5% and more polar isomer 36.6 mg, 13.3%); from 3-(1,2,3,5,8,8a-hexahydro-7-indolizinyl)-6-azaindole (270 mg, 1.13 mmol) and 10% Pd/C (300 mg) in ethanol (4 mL) under H2 overnight.
후처리
- customovernight
출처 및 근거
- ORD 기록
- ord-145394e950e849a29971efb8fb52344b
- 출처 데이터셋
- uspto-grants-2012_04
- 특허 번호
- US08148394B2
반응 노트
불러오는 중…